The general direction of our laboratory...

More than 90% of all cases begin in the mucous membrane site (oral, nasal, upper and lower respiratory cheap strattera tract, eyes, intestines and genitourinary). The general direction of our laboratory to understand the earliest events in Gram-positive bacterial infections, so that we can develop strategies to intervene in these processes and prevent infection before it starts. To this end, we participate in the four areas of research, d) development of bacteriophage (phage or) lysine gram-positive pathogens to be used as the decolonization of human mucous membranes and treatment of infections caused by these microorganisms, II) to understand the earliest events

S. pyogenes

infection, so that methods can be developed to prevent them, c) determine the mechanism by which Gram-positive bacteria attach to the cell surface proteins, and develop methods to block this application, because the bare bacteria can not cause infection, and IV) develop strategies mucosal vaccine induce a local immune response to prevent

S. pyogenes

colonization and infection. Our laboratory is also involved in research to understand the role of phages in the modulation of pathogenic bacteria in their ability to cause disease and survive in the environment. For these studies we use

S. pyogenes

bacilli and anthrax as model organisms. Since many pathogenic Gram-positive bacterial phage systems (lysogenic and dangerous), it is clear that these viruses play an important role in these bacteria. .